| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.3M | +41.5% |
| SG&A Expense | $5.6M | +114.6% |
| Operating Income | -$9.9M | -75.5% |
| Net Income | -$9.9M | -56.4% |
| EPS (Basic) | -$1.09 | +9.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.4M | -71.1% |
| Short-term Investments | $2.0M | — |
| Current Assets | $7.3M | -55.4% |
| Total Assets | $7.3M | -55.4% |
| Total Liabilities | $1.1M | +17.5% |
| Stockholders' Equity | $6.2M | -59.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.8M | -48.9% |
| Investing Cash Flow | -$2.0M | — |
| Financing Cash Flow | $42K | -99.8% |